Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
Spyre Therapeutics (SYRE) has experienced a notable pullback in recent trading, with the stock slipping roughly 2% to $74.14. This decline brings the shares closer to their established support level near $70.43, while resistance remains around $77.85. Volume over the past several sessions has been m
Spyre Therapeutics (SYRE) Stock: Down -2.00%, Support Test at $70.43 2026-05-15 - High Volume Stocks
SYRE - Stock Analysis
4892 Comments
1813 Likes
1
Sasuke
Engaged Reader
2 hours ago
Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health and management confidence. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects and future outlook. We provide 13D filings, insider buying and selling data, and trend analysis for comprehensive coverage. Get inside information with our comprehensive insider tracking and analysis tools for informed investment decisions.
👍 84
Reply
2
Tanaia
Loyal User
5 hours ago
I feel smarter just scrolling past this.
👍 94
Reply
3
Brittnea
Experienced Member
1 day ago
Investor sentiment is slightly positive, but global uncertainty may cause intermittent pullbacks.
👍 76
Reply
4
Stuti
Legendary User
1 day ago
Who’s been watching this like me?
👍 287
Reply
5
Angenita
New Visitor
2 days ago
I wish I didn’t rush into things.
👍 161
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.